Loxapine
- Generic Name
- Loxapine
- Brand Names
- Adasuve, Xylac
- Drug Type
- Small Molecule
- Chemical Formula
- C18H18ClN3O
- CAS Number
- 1977-10-2
- Unique Ingredient Identifier
- LER583670J
- Background
An antipsychotic agent used in schizophrenia. [PubChem]
- Indication
For the management of the manifestations of psychotic disorders such as schizophrenia
- Associated Conditions
- Acute Agitation, Schizophrenia
Randomized Double-blind Trial of Midazolam and Loxapine in Agitated Patients
Phase 3
Terminated
- Conditions
- Acute Agitated Patients
- Interventions
- Biological: blood sampleOther: patient monitoring
- First Posted Date
- 2006-02-10
- Last Posted Date
- 2015-03-11
- Lead Sponsor
- University Hospital, Rouen
- Target Recruit Count
- 120
- Registration Number
- NCT00290082
- Locations
- 🇫🇷
Emergency Department, St Etienne, France
🇫🇷Emergecy department, Argenteuil, France
Loxapine and Weaning From Ventilator
Not Applicable
Completed
- Conditions
- Respiratory InsufficiencyPsychomotor Agitation
- First Posted Date
- 2005-07-22
- Last Posted Date
- 2007-07-23
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 9
- Registration Number
- NCT00122733
- Locations
- 🇫🇷
Service de Réanimation, Hopital Louis Mourier, Colombes, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath